Monalizumab Biosimilar - Research Grade,ichor.bio,ICH5017
Detects human CD159a. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Monalizumab.
Host
CHO cells
Reactivity
Human
Platform ID
BAB137588162
ichor.bio
Contact
Tel:
Fax:
Email:
Product Specifications
Scientific Background
Synonyms
Specifications
NameMonalizumab Biosimilar - Research Grade
Cat. No.ICH5017
Accession NumberP26715
HostCHO cells
IsotypeHuman IgG4
ReactivityHuman
Concentration5mg/ml
TargetNKG2A
Purity>95% by SDS-PAGE
Endotoxin Level≤ 1.0 EU/mg as determined by the LAL method
ShippingBlue ice
FormulationICH3002
StorageThis biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Regulatory StatusFor research use only
Scientific Background
RUO monalizumab is a blocking antibody that prevents the inhibition of CD8+ T cells and NK cell by tumor cells expressing HLA-E. By acting simultaneously on innate and adaptive immunity, monalizumab may re-establish a broad anti-tumor response.
Synonyms
KLRC1,NKG2A,CD159a,CD94
Category Paths
- Products>Primary Antibodies>Biosimilar Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.